title: Decline of antibodies in XLA infant: when to start IVIG.
authors.affiliation: Allergy and Immunology, Texas Children’s Hospital, Houston, TX 77030-2399, USA.
authors.forename: I U
authors.initials: IU
authors.lastname: Okocha
authors.forename: C G
authors.initials: CG
authors.lastname: Hanson
authors.forename: J
authors.initials: J
authors.lastname: Chinen
authors.forename: W T
authors.initials: WT
authors.lastname: Shearer
mesh_terms: D000077329:Agammaglobulinaemia Tyrosine Kinase; D000361:Agammaglobulinemia / Q000175:diagnosis / Q000235:genetics / Q000276:immunology / Q000628:therapy; D019943:Amino Acid Substitution; D003062:Codon; D040181:Genetic Diseases, X-Linked / Q000175:diagnosis / Q000235:genetics / Q000276:immunology / Q000628:therapy; D006801:Humans; D007132:Immunoglobulin Isotypes / Q000097:blood*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D016130:Immunophenotyping; D007223:Infant; D008297:Male; D009154:Mutation; D011505:Protein-Tyrosine Kinases / Q000235:genetics; D016896:Treatment Outcome
chemical_list: D003062:Codon; D007132:Immunoglobulin Isotypes; D016756:Immunoglobulins, Intravenous; D011505:Protein-Tyrosine Kinases; D000077329:Agammaglobulinaemia Tyrosine Kinase